Figures & data
Figure 1 Flow chart synthesizing the clinical pathways of the COVID-19 patients, the respiratory support provided at each step of their hospital stay, and their 60-day mortality. Percentages refer to the previous level in the flow chart, unless otherwise indicated. *With respect to total hospital admissions.
![Figure 1 Flow chart synthesizing the clinical pathways of the COVID-19 patients, the respiratory support provided at each step of their hospital stay, and their 60-day mortality. Percentages refer to the previous level in the flow chart, unless otherwise indicated. *With respect to total hospital admissions.](/cms/asset/d061d78c-0144-49bc-89b6-bc43c24b17ed/dcle_a_12163314_f0001_c.jpg)
Table 1 Comparison of Demographic Characteristics and Administered Medications Among the Study Subgroups
Figure 2 (A) Duration of continuous non-invasive ventilation (NIV) for patients who received at least one trial of NIV (n=71). (B) Interval between hospital admission and the onset of invasive mechanical ventilation (IMV) for patients admitted to the intensive care unit (n=66). (C) Length of IMV in patients who survived or died at the 60-day follow-up.
![Figure 2 (A) Duration of continuous non-invasive ventilation (NIV) for patients who received at least one trial of NIV (n=71). (B) Interval between hospital admission and the onset of invasive mechanical ventilation (IMV) for patients admitted to the intensive care unit (n=66). (C) Length of IMV in patients who survived or died at the 60-day follow-up.](/cms/asset/087143b6-3e05-4bbb-979b-222daae74c99/dcle_a_12163314_f0002_c.jpg)
Table 2 Characteristics of Patients Receiving Either Invasive or Non-Invasive Mechanical Ventilation
Figure 3 Crude (A) and adjusted (B) Kaplan–Meier curves for the risk of 60-day mortality in patients belonging to the study groups according to the provided respiratory support.
![Figure 3 Crude (A) and adjusted (B) Kaplan–Meier curves for the risk of 60-day mortality in patients belonging to the study groups according to the provided respiratory support.](/cms/asset/4063074c-b695-4071-8a21-b99b83c0befc/dcle_a_12163314_f0003_c.jpg)
Table 3 Comparison of Mortality Rate Among Study Subgroups